Nasdaq-listed soft drinks maker PepsiCo’s agreement to buy US peer Rockstar Energy Drinks for $3.85bn would normally go down in the cannon of tales about how you can make it big without venture capital given founder Russell Weiner owned 85% of the company and his mother and chief financial officer the remainder.

Bristol Myers Squibb and Otsuka Pharmaceutical committing to LSP’s $600m life sciences fund is a further sign of the integration between strategic and financial investors.

Koch Disruptive Technologies (KDT), a subsidiary of Koch Industries, is living up to its name.

Venture capital gets a well-deserved bad rap for its general lack of diversity.

As the snows start melting near the Arctic circle with the spring thaw on its way so there has also been a warming in investor attention to the local entrepreneurs.

There’s been some big moves in the past few weeks with Accenture Ventures adding two managing directors, Tom Lounibos and Jake Kaldenbaugh, to join Michael Redding, and Brittany Skoda leaving Workday Ventures to rejoin investment banking at Morgan Stanley.

Two types of healthcare deals and two types of corporate backers.

Congratulations to GCV Emerging Leaders Awards 2020 winner Sherry House, head of corporate development at Waymo, and the team under CEO John Krafcik, for its success in raising $2.25bn in its first external funding round.

Daren Fonda’s excellent article in Barron’s, Venture Capital Attracts the Corporate Crowd, rightly asks why corporate capital is flooding in as deal activity and valuations may be peaking.

DoorDash said it was preparing an initial public offering (IPO) and had filed confidential documents with the US regulators as a first step.